| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50072 |
MRC-9 |
human |
lung |
Normal diploid fibroblasts with limited life span (crisis PDL = 44). |
|
| 2 | general cells |
IFO50112 |
TaD-1 |
rat |
thymus |
thymoma, keratin-positive, (ACI x BUF/Mna, F1 rat) |
|
| 3 | general cells |
IFO50161 |
KT-5 |
mouse |
brain |
GFAP and S-100-positive, MBP, thy-1 and neurofilament-negative. (Tested at the IFO.). |
|
| 4 | general cells |
IFO50294 |
MEG-01SSF |
human |
bone marrow |
leukemia, chronic megakaryoblastic, MEG-01s-derivative adapted to serum-free medium |
|
| 5 | general cells |
IFO50295 |
NB-1 |
human |
sympatho-adrenal cell |
neuroblastoma |
|
| 6 | general cells |
IFO50311 |
SKG-IIIb |
human |
uterine cervix |
cervical epidermoid carcinoma, large cell, non-keratinizing type |
|
| 7 | general cells |
IFO50355 |
ONS-76 |
human |
brain |
medulloblastoma |
|
| 8 | general cells |
IFO50369 |
no.11 |
human |
brain |
glioma, anaplastic, GFAP-positive |
|
| 9 | general cells |
IFO50376 |
MSS62 |
mouse |
spleen |
spleen stromal cell line, (C57BL/6 mouse) |
|
| 10 | general cells |
JCRB0076 |
A549 |
human |
lung |
Human adeno carcinoma cell line derived from lung cancer. |
|
| 11 | general cells |
JCRB0079 |
LU65 |
human |
lung |
Human cell line with giant cell carcinoma of lung. |
|
| 12 | general cells |
JCRB0152.1 |
M |
rat |
liver |
Cell line which is derived from RLC-3 (JAR rat) after 54 day-culture by Nagisa method with treatment of DAB(10ug/ml) for one week. Cells are capable to form collagen network. |
|
| 13 | general cells |
JCRB0158.2 |
MY-M13 |
human |
peripheral blood |
Subclone of the MY cells, human bone marrow mononulcear cells. |
|
| 14 | general cells |
JCRB0212 |
B82 |
mouse |
skin |
skin fibroblast, bromodeoxyuridine-resistant |
|
| 15 | general cells |
JCRB0420 |
dRLN-6 |
rat |
liver |
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) |
|
| 16 | general cells |
JCRB0506.1 |
SVts-8 |
human |
lung |
Human normal diploid fibroblast cell line transformed with SV40(ts) early gene. Cell culture at 34 C. |
|
| 17 | general cells |
JCRB0518 |
WI-38-40 |
human |
lung |
Normal primary cells from lung as well as JCRB0517. Now only the JCRB0518 with PDL 40 is available. |
|
| 18 | general cells |
JCRB0605 |
L.P3(S) |
mouse |
connective tissue |
L cell derived, L.P3(F) is the derivative of serum-free adopted L.P3, which was again cultivated in serum-containing medium. (C3H mouse) |
|
| 19 | general cells |
JCRB0746 |
YKG-1 |
human |
brain |
glioblastoma |
|
| 20 | general cells |
JCRB1014 |
KMRM-M1 |
human |
muscle |
Human renal cancer cell line metastasized to muscle. |
|
| 21 | general cells |
JCRB1044 |
OVKATE |
human |
ovary |
Human cell line derived from ovarian tumor. |
|
| 22 | general cells |
JCRB1047 |
OVSAYO |
human |
ovary |
Human cell line derived from ovarian tumour. |
|
| 23 | general cells |
JCRB1052 |
PA-1/6TG-r |
human |
ascites fluid |
Human teratocarcinoma cell line PA-1 with 6TG resistance. |
|
| 24 | general cells |
JCRB1102 |
cs-17-25 |
hamster, Chinese |
lung |
Temperature sensitive mutant of Chinese hamster lung cell line. |
|
| 25 | general cells |
JCRB1225 |
I51T |
mouse |
skin |
Mouse behta-galactosidase deficient cell line introduced human defcient bethta-galactosidase gene. |
|
| 26 | general cells |
JCRB1326 |
NCC-RbC-60 |
human |
primary retinoblastoma |
Huaman retinoblastoma cell line. The growth is very slow. |
|
| 27 | general cells |
JCRB1353 |
TER-119 |
mouse x rat |
|
Hybridoma cell line producing antibody against mouse erythrocyte membrane antigen Ly76. |
|
| 28 | general cells |
JCRB1381 |
HBs128 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against HBs antigen. |
|
| 29 | general cells |
JCRB1417 |
KYSE960 |
human |
esophagus |
Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. |
|
| 30 | general cells |
JCRB1616 |
hTf/CHO-S #17 |
hamster, Chinese |
ovary |
This cell line produce human transferrin. |
|
| 31 | general cells |
JCRB1705 |
ASF-4-5L1 |
human |
skin |
Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages. |
|
| 32 | general cells |
JCRB2204 |
A9(Neo4) |
human chromosome-introduced |
skin |
contains human chromosome # 4 (MTA with Tottori Univ. is required.) |
|
| 33 | general cells |
JCRB2206 |
A9(Neo6) |
human chromosome-introduced |
skin |
contains human chromosome # 6 (MTA with Tottori Univ. is required.) |
|
| 34 | general cells |
JCRB2213 |
A9(Hygro13) |
human chromosome-introduced |
skin |
contains human chromosome #13 (MTA with Tottori Univ. is required.)
|
|
| 35 | general cells |
JCRB2218 |
A9(Neo18) |
human chromosome-introduced |
skin |
contains human chromosome #18 (MTA with Tottori Univ. is required.) |
|
| 36 | general cells |
JCRB4016 |
WILL3 |
human |
bone marrow |
Human diffuse large B-cell lymphoma cell line with two translocations t(14;18)(q32; q21) and t(8;22)(q24;q11). |
|
| 37 | general cells |
JCRB4037 |
KMS21R |
human |
bone marrow |
Lenalidomide-resistant human myeloma cell line established by
long-term exposure of KMS21 cells to low concentration lenalidomide for about one year. |
|
| 38 | general cells |
JCRB4059 |
KMS21RF |
human |
bone marrow |
Human myeloma cell line established by culture of KMS21R cells without lenalidomide for about one month |
|
| 39 | general cells |
JCRB4080 |
NCC-GCTB6-C1 |
human |
Right distal femur |
Giant cell tumor cell line |
|
| 40 | general cells |
JCRB9113 |
HT-1080 |
human |
|
Human sarcoma cell line with activated N-ras oncogne. |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.